Guideline on the Management of Hand Eczema ICD‐10 Code: L20. L23. L24. L25. L30

Diepgen, Thomas L.; Elsner, Peter; Schliemann, Sibylle; Fartasch, ManigÃ©; KÃ¶llner, Arno; Skudlik, Christoph; John, Swen Malte; Worm, Margitta

doi:10.1111/j.1610-0379.2009.07061.x

Cited by 66 publications

(108 citation statements)

References 87 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[9][10][11] Its prevalence has more than doubled in industrialized countries with no clear cause 10 and at high cost. 11 Atopic dermatitis signs include dryness, lichenification, scaling, and occasionally nummular lesions.…”

Section: The Role Of the Skin Microbiome In Atopic Dermatitismentioning

confidence: 99%

The Skin Microbiome in Atopic Dermatitis and Its Relationship to Emollients

et al. 2015

View full text Add to dashboard Cite

Background: Human-associated bacterial communities on the skin, skin microbiome, likely play a central role in development of immunity and protection from pathogens. In atopic patients, the skin bacterial diversity is smaller than in healthy subjects. Objective: To review treatment strategies for atopic dermatitis in Canada, taking the skin microbiome concept into account. Methods: An expert panel of 8 Canadian dermatologists explored the role of skin microbiome in clinical dermatology, specifically looking at atopic dermatitis. Results: The panel reached consensus on the following: (1) In atopic patients, the skin microbiome of lesional atopic skin is different from nonlesional skin in adjacent areas. (2) Worsening atopic dermatitis and smaller bacterial diversity are strongly associated. (3) Application of emollients containing antioxidant and antibacterial components may increase microbiome diversity in atopic skin. Conclusion:The skin microbiome may be the next frontier in preventive health and may impact the approach to atopic dermatitis treatment.

show abstract

Section: The Role Of the Skin Microbiome In Atopic Dermatitismentioning

confidence: 99%

The Skin Microbiome in Atopic Dermatitis and Its Relationship to Emollients

et al. 2015

View full text Add to dashboard Cite

show abstract

“…8,20 In addition, there is a consensus statement from the United Kingdom 22 and a guideline from a Canadian group of experts. 7 The American Academy of Dermatology has published guidelines on the use of topical glucocorticoids, the mainstay of treatment for hand eczema.…”

Section: Guidel Ine Smentioning

confidence: 99%

“…19 Current treatment strategies are largely based on clinical experience and may differ from country to country. 7,8,20 Few therapies have been evaluated in randomized, controlled trials, 21 and the trials that have been conducted typically have not distinguished types of eczema. Figure 3 shows an algorithm for the management of hand eczema.…”

Section: Hand Eczemamentioning

confidence: 99%

Hand Eczema

2012

View full text Add to dashboard Cite

show abstract

“…CHE is a common dermatological condition with frequent relapses, occurs possibly as a result of long-term exposure to various irritants and allergens (2,3). Up to 70% of cases of CHE are severe (4), and its treatment has proven to be a considerably difficult task for dermatologists.…”

Section: Introductionmentioning

confidence: 99%

“…Although its efficacy is limited, it is considered to be relatively safe (3,7). Systemic treatments are indicated for refractory CHE, the majority of which have not been investigated in randomized clinical trials and are therefore prescribed off-label (2,3,8). At present, the only treatments approved are alitretinoin, which may be considered a second-line option as it has shown good response rates in clinical trials and observational studies (9)(10)(11)(12).…”

Section: Introductionmentioning

confidence: 99%

Successful treatment of refractory chronic hand eczema with calcipotriol/betamethasone ointment: A report of three cases

Yang

Chang

2015

Experimental and Therapeutic Medicine

View full text Add to dashboard Cite

Abstract. Chronic hand eczema (CHE) is a common skin disorder with frequent relapses, and its treatment comprises a challenge due to its uncertain etiology. In particular, certain cases of CHE exhibiting severe keratinization have a very poor response to various treatments. The Daivobet ointment, a complex product comprising calcipotriol and betamethasone, has been successfully used for the treatment of patients with plaque-type psoriasis for ~10 years; however, there are few reports on the effect of the ointment on other skin disorders of abnormal keratinization, such as eczema. The present study reported 3 cases of refractory hyperkeratotic eczema of the hand that did not respond to several treatments, but responded well to topical Daivobet treatment.

show abstract

Guideline on the Management of Hand Eczema ICD‐10 Code: L20. L23. L24. L25. L30

Cited by 66 publications

References 87 publications

The Skin Microbiome in Atopic Dermatitis and Its Relationship to Emollients

The Skin Microbiome in Atopic Dermatitis and Its Relationship to Emollients

Hand Eczema

Successful treatment of refractory chronic hand eczema with calcipotriol/betamethasone ointment: A report of three cases

Contact Info

Product

Resources

About